FMR LLC 13D and 13G filings for Atea Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 09:50 am Purchase | 2024-11-08 | 13G | Atea Pharmaceuticals, Inc. AVIR | FMR LLC | 6,618,297 7.839% | 1,267,638 (+23.69%) | Filing |
| 2024-02-09 08:35 am Sale | 2024-02-08 | 13G | Atea Pharmaceuticals, Inc. AVIR | FMR LLC | 5,350,659 6.412% | -1,723,628 (-24.36%) | Filing |
| 2023-09-11 08:23 am Sale | 2023-09-08 | 13G | Atea Pharmaceuticals, Inc. AVIR | FMR LLC | 7,074,287 8.482% | -4,663,122 (-39.73%) | Filing |
| 2023-02-09 08:23 am Sale | 2023-02-09 | 13G | Atea Pharmaceuticals, Inc. AVIR | FMR LLC | 11,737,409 14.092% | -728,000 (-5.84%) | Filing |
| 2022-02-09 09:09 am Purchase | 2022-02-08 | 13G | Atea Pharmaceuticals, Inc. AVIR | FMR LLC | 12,465,409 14.999% | 3,879,374 (+45.18%) | Filing |
| 2021-03-10 09:46 am Purchase | 2021-03-09 | 13G | Atea Pharmaceuticals, Inc. AVIR | FMR LLC | 8,586,035 10.392% | 2,138,344 (+33.16%) | Filing |
| 2021-02-08 10:15 am Purchase | 2021-02-05 | 13G | Atea Pharmaceuticals, Inc. AVIR | FMR LLC | 6,447,691 7.804% | 6,447,691 (New Position) | Filing |